OpenURL Connection Search

Select item for more details and to access through your institution.

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
Published in:
2017
By:
- Baselga, José;
- Zamagni, Claudio;
- Gómez, Patricia;
- Bermejo, Begoña;
- Nagai, Shigenori E.;
- Melichar, Bohuslav;
- Chan, Arlene;
- Mángel, Lászlo;
- Bergh, Jonas;
- Costa, Frederico;
- Gómez, Henry L.;
- Gradishar, William J.;
- Hudis, Clifford A.;
- Rapoport, Bernardo L.;
- Roché, Henri;
- Maeda, Patricia;
- Huang, Liping;
- Meinhardt, Gerold;
- Zhang, Joshua;
- Schwartzberg, Lee S.
Publication type:
journal article
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.
Published in:
Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 117, doi. 10.1007/s10549-021-06184-w
By:
- Masuda, Norikazu;
- Bando, Hiroko;
- Yamanaka, Takashi;
- Kadoya, Takayuki;
- Takahashi, Masato;
- Nagai, Shigenori E.;
- Ohtani, Shoichiro;
- Aruga, Tomoyuki;
- Suzuki, Eiji;
- Kikawa, Yuichiro;
- Yasojima, Hiroyuki;
- Kasai, Hiroi;
- Ishiguro, Hiroshi;
- Kawabata, Hidetaka;
- Morita, Satoshi;
- Haga, Hironori;
- Kataoka, Tatsuki R.;
- Uozumi, Ryuji;
- Ohno, Shinji;
- Toi, Masakazu
Publication type:
Article
The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study.
Published in:
Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 125, doi. 10.1007/s10549-020-05921-x
By:
- Takahashi, Masato;
- Ohtani, Shoichiro;
- Nagai, Shigenori E.;
- Takashima, Seiki;
- Yamaguchi, Miki;
- Tsuneizumi, Michiko;
- Komoike, Yoshifumi;
- Osako, Tomofumi;
- Ito, Yoshinori;
- Ikeda, Masahiko;
- Ishida, Kazushige;
- Nakayama, Takahiro;
- Takashima, Tsutomu;
- Asakawa, Takashi;
- Matsumoto, Sho;
- Shimizu, Daisuke;
- Masuda, Norikazu
Publication type:
Article
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study.
Published in:
Investigational New Drugs, 2020, v. 38, n. 1, p. 140, doi. 10.1007/s10637-019-00829-w
By:
- Inoue, Kenichi;
- Nagai, Shigenori E.;
- Saito, Tsuyoshi;
- Sakurai, Takashi;
- Kimizuka, Kei;
- Yamada, Hirofumi;
- Kuroda, Toru;
- Hata, Satoshi;
- Yamazaki, Yasuo;
- Kojima, Masato;
- Futsuhara, Kazushige
Publication type:
Article
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.
Published in:
2019
By:
- Fujiwara, Yasuhiro;
- Mukai, Hirofumi;
- Saeki, Toshiaki;
- Ro, Jungsil;
- Lin, Yung-Chang;
- Nagai, Shigenori E.;
- Lee, Keun Seok;
- Watanabe, Junichiro;
- Ohtani, Shoichiro;
- Kim, Sung Bae;
- Kuroi, Katsumasa;
- Tsugawa, Koichiro;
- Tokuda, Yutaka;
- Iwata, Hiroji;
- Park, Yeon Hee;
- Yang, Youngsen;
- Nambu, Yoshihiro
Publication type:
journal article
Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93620-y
By:
- Tozuka, Katsunori;
- Wongsirisin, Pattama;
- Nagai, Shigenori E.;
- Kobayashi, Yasuhito;
- Kanno, Miki;
- Kubo, Kazuyuki;
- Takai, Ken;
- Inoue, Kenichi;
- Matsumoto, Hiroshi;
- Shimizu, Yoshihito;
- Suganuma, Masami
Publication type:
Article
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study
Published in:
Breast Cancer (13406868), 2024, v. 31, n. 4, p. 621, doi. 10.1007/s12282-024-01575-5
By:
- Yoshinami, Tetsuhiro;
- Nagai, Shigenori E.;
- Hattori, Masaya;
- Okamura, Takuho;
- Watanabe, Kenichi;
- Nakayama, Takahiro;
- Masuda, Hiroko;
- Tsuneizumi, Michiko;
- Takabatake, Daisuke;
- Harao, Michiko;
- Yoshino, Hiroshi;
- Mori, Natsuko;
- Yasojima, Hiroyuki;
- Oshiro, Chiya;
- Iwase, Madoka;
- Yamaguchi, Miki;
- Sangai, Takafumi;
- Kosaka, Nobuyoshi;
- Tajima, Kentaro;
- Masuda, Norikazu
Publication type:
Article
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
Published in:
2021
By:
- Shimoi, Tatsunori;
- Nagai, Shigenori E.;
- Yoshinami, Tetsuhiro;
- Takahashi, Masato;
- Arioka, Hitoshi;
- Ishihara, Mikiya;
- Kikawa, Yuichiro;
- Koizumi, Kei;
- Kondo, Naoto;
- Sagara, Yasuaki;
- Takada, Masahiro;
- Takano, Toshimi;
- Tsurutani, Junji;
- Naito, Yoichi;
- Nakamura, Rikiya;
- Hattori, Masaya;
- Hara, Fimikata;
- Hayashi, Naoki;
- Mizuno, Toshiro;
- Miyashita, Minoru
Publication type:
Correction Notice
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
Published in:
Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
By:
- Shimoi, Tatsunori;
- Nagai, Shigenori E.;
- Yoshinami, Tetsuhiro;
- Takahashi, Masato;
- Arioka, Hitoshi;
- Ishihara, Mikiya;
- Kikawa, Yuichiro;
- Koizumi, Kei;
- Kondo, Naoto;
- Sagara, Yasuaki;
- Takada, Masahiro;
- Takano, Toshimi;
- Tsurutani, Junji;
- Naito, Yoichi;
- Nakamura, Rikiya;
- Hattori, Masaya;
- Hara, Fimikata;
- Hayashi, Naoki;
- Mizuno, Toshiro;
- Miyashita, Minoru
Publication type:
Article
Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
Published in:
Breast Cancer (13406868), 2020, v. 27, n. 3, p. 334, doi. 10.1007/s12282-019-01039-1
By:
- Yoshinami, Tetsuhiro;
- Koizumi, Kei;
- Nagai, Shigenori E.;
- Toyama, Tatsuya;
- Iwata, Hiroji
Publication type:
Article
Multicenter Observational Study of Fulvestrant 500 mg in Postmenopausal Japanese Women with Estrogen Receptor-Positive Advanced or Recurrent Breast Cancer after Prior Endocrine Treatment (SBCCSG29 Study).
Published in:
Journal of Nippon Medical School, 2019, v. 86, n. 3, p. 165, doi. 10.1272/jnms.JNMS.2019_86-305
By:
- Kei Kimizuka;
- Kenichi Inoue;
- Shigenori E. Nagai;
- Tsuyoshi Saito;
- Satoko Nakano;
- Kazushige Futsuhara;
- Hirofumi Yamada;
- Shiori Kaneko;
- Takashi Sakurai;
- Satoshi Hata;
- Masafumi Kurosumi
Publication type:
Article
A Real-World Retrospective Cohort Study of Combined Therapy with Bevacizumab and Paclitaxel in Japanese Patients with Metastatic Breast Cancer.
Published in:
Journal of Nippon Medical School, 2017, v. 84, n. 5, p. 215
By:
- Hirofumi Yamada;
- Kenichi Inoue;
- Nagai, Shigenori E.;
- Maki Nakai;
- Fumio Arisawa;
- Hiroyuki Ueda;
- Tsuyoshi Saito;
- Jun Ninomiya;
- Toru Kuroda;
- Takashi Sakurai;
- Hitomi Kodama;
- Kei Kimizuka;
- Satoshi Hata;
- Toshihiro Kai;
- Masafumi Kurosumi
Publication type:
Article

Found: 12